Telemedicine Use and Quality of Opioid Use Disorder Treatment During Pandemic

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, JANUARY 24, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.52381?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=012423

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: The results of this study indicated that clinical outcomes were similar among patients with opioid use disorder who were treated by clinicians with high and low telemedicine use during the COVID-19 pandemic, suggesting that telemedicine is a comparable alternative to in-person opioid use disorder care. There was no evidence that telemedicine was associated with increased access to or improved quality of opioid use disorder treatment. 

Authors: Michael L. Barnett, M.D., M.S., of the Harvard T.H. Chan School of Public Health in Boston, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2022.52381)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.